Sign In
Buy NA-PE
National Bank of Canada Non-Cum Conv Red Perp Pfd Registered Shs Series -40- Earnings Calls
| Release date | Dec 03, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 0.436% |
| Release date | Aug 27, 2025 |
| EPS estimate | $2.71 |
| EPS actual | $3.09 |
| EPS Surprise | 14.02% |
| Revenue estimate | 3.43B |
| Revenue actual | 7.704B |
| Revenue Surprise | 124.60% |
| Release date | May 28, 2025 |
| EPS estimate | - |
| EPS actual | $2.60 |
| Revenue estimate | 3.229B |
| Revenue actual | 7.706B |
| Revenue Surprise | 138.65% |
| Release date | Feb 26, 2025 |
| EPS estimate | - |
| EPS actual | $2.89 |
| Revenue estimate | 3.304B |
| Revenue actual | 3.231B |
| Revenue Surprise | -2.21% |
Last 4 Quarters for National Bank of Canada Non-Cum Conv Red Perp Pfd Registered Shs Series -40-
Below you can see how NA-PE.TO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 26, 2025 |
| Price on release | $25.30 |
| EPS estimate | - |
| EPS actual | $2.89 |
| Date | Price |
|---|---|
| Feb 20, 2025 | $25.30 |
| Feb 21, 2025 | $25.40 |
| Feb 24, 2025 | $25.43 |
| Feb 25, 2025 | $25.22 |
| Feb 26, 2025 | $25.30 |
| Feb 27, 2025 | $25.20 |
| Feb 28, 2025 | $25.09 |
| Mar 03, 2025 | $24.99 |
| Mar 04, 2025 | $24.89 |
| 4 days before | 0% |
| 4 days after | -1.62% |
| On release day | -0.395% |
| Change in period | -1.62% |
| Release date | May 28, 2025 |
| Price on release | $25.35 |
| EPS estimate | - |
| EPS actual | $2.60 |
| Date | Price |
|---|---|
| May 22, 2025 | $25.01 |
| May 23, 2025 | $25.19 |
| May 26, 2025 | $25.31 |
| May 27, 2025 | $25.35 |
| May 28, 2025 | $25.35 |
| May 29, 2025 | $25.35 |
| May 30, 2025 | $25.25 |
| Jun 02, 2025 | $25.31 |
| Jun 03, 2025 | $25.22 |
| 4 days before | 1.36% |
| 4 days after | -0.513% |
| On release day | 0% |
| Change in period | 0.84% |
| Release date | Aug 27, 2025 |
| Price on release | $25.42 |
| EPS estimate | $2.71 |
| EPS actual | $3.09 |
| EPS surprise | 14.02% |
| Date | Price |
|---|---|
| Aug 21, 2025 | $25.27 |
| Aug 22, 2025 | $25.40 |
| Aug 25, 2025 | $25.41 |
| Aug 26, 2025 | $25.37 |
| Aug 27, 2025 | $25.42 |
| Aug 28, 2025 | $25.38 |
| Aug 29, 2025 | $25.42 |
| Sep 02, 2025 | $25.47 |
| Sep 03, 2025 | $25.43 |
| 4 days before | 0.594% |
| 4 days after | 0.0393% |
| On release day | -0.157% |
| Change in period | 0.633% |
| Release date | Dec 03, 2025 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $25.66 |
| Nov 12, 2025 | $25.74 |
| Nov 13, 2025 | $25.64 |
| Nov 14, 2025 | $25.51 |
| Nov 17, 2025 | $25.55 |
National Bank of Canada Non-Cum Conv Red Perp Pfd Registered Shs Series -40- Earnings Call Transcript Summary of Q3 2025
National Bank reported Q3 2025 EPS of $2.68 and a 14% ROE, driven by broad-based revenue strength, positive operating leverage and early benefits from the CWB acquisition. All-bank revenue rose 19% YoY (PTPP +21%), with organic revenue growth of 10% excluding CWB. The bank ended the quarter with CET1 of 13.9% (internal capital generation +33 bps) and announced an intention to repurchase up to 8 million shares; dividend policy will be reviewed next quarter. CWB integration is progressing: first client migrations completed, $69M of synergies realized to date (annualized $173M, 64% of the 3-year target) and management expects to hit the Year 1 synergy target of $135M by Dec 2025 and to discuss revenue synergies on the Q4 call. Balance-sheet momentum: loans +7% YoY (ex. CWB), deposits +11% YoY (ex. CWB), NII (ex-trading) stable quarter-over-quarter with all-bank NIM ~2.22%. Credit remains resilient: total PCLs $203M (28 bps), allowances $2.3B (5x net charge-offs), impaired loan ratio 102 bps; management expects impaired PCLs to finish near the middle of its 25–35 bps full-year range. Key near-term investor considerations are: pace of CWB migrations (and resulting revenue synergies), timing/size of capital benefit from AIRB conversion (expected late 2026), the announced buyback and upcoming dividend review, and exposure to tariff/geopolitical risks that may affect certain industry credits.
